MINEOLA, NY (KTRK) -- A recently FDA-approved procedure will make weight-loss surgery available to people who may not have been candidates for gastric bypass and other weight loss surgeries. The ...
ST. PAUL, Minn., Jan. 5, 2017 /PRNewswire/ -- EnteroMedics Inc. (NASDAQ:ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other ...
There may be new hope for people struggling with obesity. It's called "VBLOC therapy," which seeks to stop the impulse to overeat by blocking the vagal nerves. Those nerves communicate feelings of ...
The company pursues a new plan intended to drive commercial adoption of its vBloc neuromodulation weight loss therapy despite current reimbursement hurdles. Marie Thibault EnteroMedics' Maestro System ...
ST. PAUL, MN--(Marketwired - Jul 25, 2013) - EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other ...
LOS ANGELES (CBSLA.com) — A device that promises to turn off hunger is the newest tool in the battle against overeating. The Food and Drug Administration last month approved the pacemaker-like device ...
The obesity rate among adults in the United States is now at 37 percent, a 12 percent increase from 2000, according to the Centers for Disease Control and Prevention (CDC). But now, technology firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results